FIELD: medicine; biology.
SUBSTANCE: method involves introducing vector containing DNA-sequence into area under protection encoding T-cadgerin and being capable of providing its expression in target tissue or cells compatible with target tissue cells transected with said vector in advance and selected with respect to T-cadgerin expression level. The method has been tested on model system by implanting Matrigel to mice. Reliable implant mass-, implant hemoglobin contents- and capillary and medium-sized blood vessel number reduction has been observed in experimental animals, receiving cells L929 (clone TC3) expressing T-cadgerin, in two weeks after the injection.
EFFECT: enhanced effectiveness in treating pathological states with new blood vessel formation being suppressed.
7 cl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CULTURING FIBROBLASTS FOR SUBSTITUTION THERAPY | 2006 |
|
RU2320720C2 |
| METHOD FOR OBTAINING CELL CULTURE WITH INDUCED ANGIOGENIC PHENOTYPE INTENDED FOR TISSUE ENGINEERING IN REGION OF ISCHEMIA | 2007 |
|
RU2334793C1 |
| VEGFopt GENE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR | 2008 |
|
RU2385937C1 |
| AGPopt GENE OF ANGIOPOIETIN-1 | 2008 |
|
RU2385938C1 |
| HGFopt GENE OF HEPATOCYTE GROWTH FACTOR | 2008 |
|
RU2385936C1 |
| METHOD FOR STIMULATING REGENERATIVE PROCESSES IN ISCHEMIC TISSUES | 2011 |
|
RU2497529C2 |
| AGENT FOR TREATMENT OF ISCHEMIC LESIONS OF TISSUES AND METHOD OF ITS USE | 2012 |
|
RU2522778C2 |
| METHOD FOR STIMULATING RECOVERED PERIPHERAL TISSUE INNERVATION | 2011 |
|
RU2486918C1 |
| METHOD OF OBTAINING POPULATION OF NEURAL DIFFERENTIATION INDUCED STROMAL CELLS OF FAT TISSUE | 2008 |
|
RU2396345C1 |
| METHOD OF ESTIMATING ANGIOGENIC POTENTIAL OF PROGENOTOR CELLS IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2011 |
|
RU2548801C2 |
